Auchus, R., Findling, J., & Moraitis, A. (2019). SUN-451 A Randomized-Withdrawal, Placebo-Controlled, Phase 3 Study to Assess the Efficacy and Safety of Selective Glucocorticoid Receptor Antagonist, Relacorilant, in Patients with Cushing Syndrome (GRACE Study). J Endocr Soc.
Citação norma ChicagoAuchus, Richard, James Findling, and Andreas Moraitis. "SUN-451 A Randomized-Withdrawal, Placebo-Controlled, Phase 3 Study to Assess the Efficacy and Safety of Selective Glucocorticoid Receptor Antagonist, Relacorilant, in Patients With Cushing Syndrome (GRACE Study)." J Endocr Soc 2019.
Citação norma MLAAuchus, Richard, James Findling, and Andreas Moraitis. "SUN-451 A Randomized-Withdrawal, Placebo-Controlled, Phase 3 Study to Assess the Efficacy and Safety of Selective Glucocorticoid Receptor Antagonist, Relacorilant, in Patients With Cushing Syndrome (GRACE Study)." J Endocr Soc 2019.